Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites
Open Access
- 15 November 2000
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (22), 10269-10273
- https://doi.org/10.1128/jvi.74.22.10269-10273.2000
Abstract
Recently, significant numbers of individuals with primary human immunodeficiency virus (HIV) infection have been found to harbor viral strains with reduced susceptibility to antiretroviral drugs. In one study, HIV from 16% of such antiretroviral-naive individuals was shown to have a susceptibility to nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) between 2.5- and 10-fold lower than that of a wild-type control. Mutations in the RT domain that had previously been associated with antiretroviral resistance were not shared by these strains. We have analyzed by logistic regression 46 variable amino acid sites in RT for their effect on susceptibility and have identified two novel sites influencing susceptibility to NNRTIs: amino acids 135 and 283 in RT. Eight different combinations of amino acids at these sites were observed among these patients. These combinations showed a 14-fold range in mean susceptibility to both nevirapine and delavirdine. In vitro mutagenesis of the control strain combined with a phenotypic assay confirmed the significance of amino acid variation at these sites for susceptibility to NNRTIs.Keywords
This publication has 23 references indexed in Scilit:
- Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug useAIDS, 2000
- Novel Four‐Drug Salvage Treatment Regimens after Failure of a Human Immunodeficiency Virus Type 1 Protease Inhibitor–Containing Regimen: Antiviral Activity and Correlation of Baseline Phenotypic Drug Susceptibility with Virologic OutcomeThe Journal of Infectious Diseases, 1999
- Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance 1 1Edited by J. KarnJournal of Molecular Biology, 1998
- Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Does Not Adversely Affect Outcome at 1 YearThe Journal of Infectious Diseases, 1996
- The genetic data environment an expandable GUI for multiple sequence analysisBioinformatics, 1994
- TRANSMISSION OF 215 MUTANTS IN PRIMARY HIV INFECTION AND ANALYSIS AFTER 6 MONTHS OF ZIDOVUDINEAIDS, 1994
- TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environmentBioinformatics, 1994
- Transmission of zidovudine-resistant HIV-1 through heterosexual contactsAIDS, 1994
- Heterosexual Transmission of Human Immunodeficiency Virus Type 1 Variants Associated with Zidovudine ResistanceThe Journal of Infectious Diseases, 1994
- Evolutionary trees from DNA sequences: A maximum likelihood approachJournal of Molecular Evolution, 1981